DocMorris AG
DOCM
Rank in Stocks
#8212
DocMorris AG is a key player in the pharmaceutical sector, focusing on both... DocMorris AG is a key player in the pharmaceutical sector, focusing on both online pharmacy services and the wholesale supply of medical and pharmaceutical goods. The company provides a comprehensive selection of items, including prescription and over-the-counter medications, health and wellness products, beauty and personal care lines, dietary supplements, pain relief remedies, and emergency first aid supplies. Furthermore, it offers specialized medication management support. In addition to its significant digital footprint, DocMorris AG also operates traditional brick-and-mortar pharmacy locations. Its commercial activities extend across Switzerland and into various international territories, serving medical practitioners, other online pharmaceutical distributors, and individual consumers directly. Notable brands within its portfolio include Zur Rose, PromoFarma, TeleClinic, and DocMorris. Established in 1993 and based in Frauenfeld, Switzerland, the company adopted its current name, DocMorris AG, in May 2023, having previously been known as Zur Rose Group AG.
Share Price
$22.82
Last synced: 2026-11-12
Market Cap
$1.12B
Change (1 day)
0.49%
Change (1 year)
238.17%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade DocMorris AG (DOCM)
Category
Healthcare
EPS for DocMorris AG (DOCM)
EPS as of June 2026 TTM: $-1.91
According to DocMorris AG's latest financial reports, its current EPS (TTM) is $-1.91. At the end of 2025 the company had an EPS of $-3.28, an increase over its 2024 EPS of $-4.49.
EPS history for DocMorris AG from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.91 | -41.85% |
| 2025 | $-3.28 | -27.10% |
| 2024 | $-4.49 | -208.93% |
| 2023 | $4.13 | -149.03% |
| 2022 | $-8.42 | -33.40% |
| 2021 | $-12.64 | 54.22% |
| 2020 | $-8.19 | 165.98% |
| 2019 | $-3.08 | 0.34% |
| 2018 | $-3.07 | -7.65% |
| 2017 | $-3.32 | 267.77% |
| 2016 | $-0.90 | -461.42% |
| 2015 | $0.25 | -51.29% |
| 2014 | $0.51 | -119.49% |
| 2013 | $-2.63 | -353.72% |
| 2012 | $1.04 | -64.15% |
| 2011 | $2.90 | 214.67% |
| 2010 | $0.92 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $39.05 | -2,147.40% |
US
|
|
| $17.99 | -1,043.22% |
US
|
|
| $7.77 | -507.38% |
US
|
|
| $17.99 | -1,043.22% |
US
|
|
| $0.04 | -102.28% |
AU
|
Questions about DocMorris AG's earnings per share (EPS)
What is DocMorris AG's earnings per share (EPS)?
DocMorris AG's earnings per share (EPS) over the last twelve months is $-1.91, as of Jun 2026.
What was DocMorris AG's earnings per share (EPS) in 2025?
In 2025, DocMorris AG's earnings per share (EPS) was $-3.28, compared with $-4.49 in 2024.
How has DocMorris AG's earnings per share (EPS) changed since 2020?
From 2020 to 2025, DocMorris AG's earnings per share (EPS) was highest in 2023 ($4.13) and lowest in 2021 ($-12.64).
How does DocMorris AG's earnings per share (EPS) compare with similar companies?
DocMorris AG's earnings per share (EPS) ($-1.91) is lower than that of all 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.